Although insulin normally suppresses synovial inflammation and catabolism, obese individuals with T2DM experience synovial inflammation that diminishes the inhibitory effect of elevated insulin levels on OA‐induced inflammation and catabolic mediators [31]. Here, INS is linked to type 2 diabetes mellitus.